Science Explorer Back to mapMap
Discussion
Researcher · München Klinik · Germany

Marc Dauer

Marc Dauer publishes mostly in Immunology, Oncology and Surgery, on topics such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

ORCID 0000-0003-2615-2523 OpenAlex
World rank
#3,217,481
of 7,710,434 ranked researchers
Rank in Germany
#160,204
of 364,343
Works
87
Citations
2.9k
Citations per work
33.7
h-index
25
i10-index 28Top 21% in Immunology
Marc Dauer

What does Marc Dauer research?

Marc Dauer's work is mostly in Medicine (40%), Immunology and Microbiology (32%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 35 works · 40.4% of their workMedicine: 35 works · 40.4% of their workOncology: 16 works · 18.7% of their workSurgery: 13 works · 14.9% of their workEpidemiology: 3 works · 3.4% of their workGastroenterology: 3 works · 3.4% of their workLife Sciences: 33 works · 37.5% of their workImmunology and Microbiology: 27 works · 31.5% of their workImmunology: 27 works · 31.5% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 6.0% of their workMolecular Biology: 5 works · 6.0% of their workEverything else: 19 works · 22.1% of their workTHEIR WORKMarc Dauer87works
Life Sciences38%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3540.4%
    1. Immunology and Microbiology2731.5%
    2. Biochemistry, Genetics and Molecular Biology56.0%
  3. Everything else1922.1%
  1. 1Immunology32% of their works
  2. 2Oncology19% of their works
  3. 3Surgery15% of their works
  4. 4Molecular Biology6% of their works
  5. 5Epidemiology3% of their works
  6. 6Gastroenterology3% of their works

Research topics

Which keywords describe Marc Dauer's research?

The keywords of their largest research topics: Cancer Immunotherapy, Dendritic Cells, Immunity, Immune Checkpoint Blockade, PD-1 and PD-L1, CAR T Cells, Chimeric Antigen Receptor and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer Immunotherapy582 topics
  2. Dendritic Cells441 topic
  3. Immunity441 topic
  4. Immune Checkpoint Blockade261 topic
  5. PD-1 and PD-L1261 topic
  6. CAR T Cells141 topic
  7. Chimeric Antigen Receptor141 topic
  8. NK Cell Recognition131 topic
  9. Natural Killer Cells131 topic
  10. Foxp391 topic
  11. TGF-ß91 topic
  12. Fc Receptors61 topic
  13. Therapeutic Antibodies61 topic
  14. RNA Interference51 topic
  15. siRNA Delivery51 topic
  16. Crohn's Disease41 topic
  17. Inflammatory Bowel Disease41 topic

Where does Marc Dauer work?

Marc Dauer's main affiliation in the publication record is München Klinik, Germany.

How many publications and citations does Marc Dauer have?

OpenAlex counts 87 works and 2,929 citations for Marc Dauer, an h-index of 25, ranking #3,217,481 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marc Dauer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.